Literature DB >> 21975193

A feasibility study of Acceptance and Commitment Therapy for emotional dysfunction following psychosis.

Ross White1, Andrew Gumley, Jackie McTaggart, Lucy Rattrie, Deirdre McConville, Seonaid Cleare, Gordon Mitchell.   

Abstract

The experience of psychosis can lead to depression, anxiety and fear. Acceptance and Commitment Therapy (ACT) facilitates individuals to accept difficult mental experiences and behave in ways that are consistent with personally held values. This study was a single (rater) blind pilot randomised controlled trial of ACT for emotional dysfunction following psychosis. Twenty-seven participants with psychosis were randomised to either: ten sessions of ACT plus treatment as usual (TAU) or TAU alone. The Hospital Anxiety and Depression Scale, Positive and Negative Syndrome Scale, Acceptance and Action Questionnaire, Kentucky Inventory of Mindfulness Skills and Working Alliance Inventory were used. Individuals were assessed at baseline and 3 months post-baseline. The individuals randomised to receive ACT found the intervention acceptable. A significantly greater proportion of the ACT group changed from being depressed at time of entry into the study to not being depressed at follow-up. The ACT group showed a significantly greater increase in mindfulness skills and reduction in negative symptoms. Results indicated that individuals randomised to ACT had significantly fewer crisis contacts over the study. Changes in mindfulness skills correlated positively with changes in depression. ACT appears to offer promise in reducing negative symptoms, depression and crisis contacts in psychosis. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21975193     DOI: 10.1016/j.brat.2011.09.003

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  20 in total

1.  Formative, multimethod case studies of learn to quit, an acceptance and commitment therapy smoking cessation app designed for people with serious mental illness.

Authors:  Roger Vilardaga; Javier Rizo; Richard K Ries; Julie A Kientz; Douglas M Ziedonis; Kayla Hernandez; Francis J McClernon
Journal:  Transl Behav Med       Date:  2019-11-25       Impact factor: 3.046

2.  Acceptance-based Behavior Therapy for Depression With Psychosis: Results From a Pilot Feasibility Randomized Controlled Trial.

Authors:  Brandon A Gaudiano; Andrew M Busch; Susan J Wenze; Kathryn Nowlan; Gary Epstein-Lubow; Ivan W Miller
Journal:  J Psychiatr Pract       Date:  2015-09       Impact factor: 1.325

3.  Comparing experiential acceptance and cognitive reappraisal as predictors of functional outcome in individuals with serious mental illness.

Authors:  Roger Vilardaga; Steven C Hayes; David C Atkins; Christie Bresee; Alaei Kambiz
Journal:  Behav Res Ther       Date:  2013-05-02

4.  Feasibility and Preliminary Effects of Implementing Acceptance and Commitment Therapy for Inpatients With Psychotic-Spectrum Disorders in a Clinical Psychiatric Intensive Care Setting.

Authors:  Brandon A Gaudiano; Stacy Ellenberg; Barbara Ostrove; Jennifer Johnson; Kim T Mueser; Martin Furman; Ivan W Miller
Journal:  J Cogn Psychother       Date:  2020-01-01

5.  An open trial of a new acceptance-based behavioral treatment for major depression with psychotic features.

Authors:  Brandon A Gaudiano; Kathryn Nowlan; Lily A Brown; Gary Epstein-Lubow; Ivan W Miller
Journal:  Behav Modif       Date:  2012-12-06

6.  The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis.

Authors:  Steffen Moritz; Fabrice Berna; Susanne Jaeger; Stefan Westermann; Matthias Nagel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-05-18       Impact factor: 5.270

7.  Mindfulness in schizophrenia: Associations with self-reported motivation, emotion regulation, dysfunctional attitudes, and negative symptoms.

Authors:  Naomi T Tabak; William P Horan; Michael F Green
Journal:  Schizophr Res       Date:  2015-07-29       Impact factor: 4.939

8.  Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness.

Authors:  Roger Vilardaga; Javier Rizo; Paige E Palenski; Paolo Mannelli; Jason A Oliver; Francis J Mcclernon
Journal:  Nicotine Tob Res       Date:  2020-08-24       Impact factor: 4.244

9.  Putting a Hold on the Downward Spiral of Paranoia in the Social World: A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Individuals with a History of Depression.

Authors:  Dina Collip; Nicole Geschwind; Frenk Peeters; Inez Myin-Germeys; Jim van Os; Marieke Wichers
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 10.  Psychiatric symptoms in glioma patients: from diagnosis to management.

Authors:  Florien W Boele; Alasdair G Rooney; Robin Grant; Martin Klein
Journal:  Neuropsychiatr Dis Treat       Date:  2015-06-10       Impact factor: 2.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.